New directions in primary biliary cirrhosis.
作者信息
Bateson M C
出版信息
BMJ. 1990 Dec 8;301(6764):1290-1. doi: 10.1136/bmj.301.6764.1290.
Abstract
摘要
相似文献
1
New directions in primary biliary cirrhosis.
BMJ. 1990 Dec 8;301(6764):1290-1. doi: 10.1136/bmj.301.6764.1290.
2
Use of ursodeoxycholic acid in primary biliary cirrhosis.熊去氧胆酸在原发性胆汁性肝硬化中的应用。
Ann Pharmacother. 1993 Dec;27(12):1472-4.
3
Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.熊去氧胆酸治疗胆汁性肝硬化的药理学研究。
Expert Opin Pharmacother. 2010 Feb;11(3):387-92. doi: 10.1517/14656560903493460.
4
Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis.熊去氧胆酸治疗原发性胆汁性肝硬化患者。
Neth J Med. 1990 Aug;37(1-2):21-3.
5
[Ursodeoxycholic acid in the treatment of primary biliary liver cirrhosis].
Gastroenterol Clin Biol. 1994;18(2 Pt 3):T5-8.
6
[Ursodeoxycholic acid in primary biliary cirrhosis. 1: Therapeutic approaches up to now and the rationale for treatment with ursodeoxycholic acid].
Fortschr Med. 1988 Nov 30;106(34):691-4.
7
[Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?].不进行肝活检使用熊去氧胆酸治疗原发性胆汁性肝硬化？
Ugeskr Laeger. 2004 Aug 2;166(32):2688; author reply 2688.
8
Ursodeoxycholic acid for primary biliary cirrhosis.熊去氧胆酸用于原发性胆汁性肝硬化。
Lancet. 1987 Aug 15;2(8555):398-9. doi: 10.1016/s0140-6736(87)92421-4.
9
Is continued enthusiasm for ursodeoxycholic acid therapy for the treatment of primary biliary cirrhosis warranted?
Hepatology. 1992 May;15(5):971-3. doi: 10.1002/hep.1840150536.
10
Ursodeoxycholic acid and primary biliary cirrhosis.熊去氧胆酸与原发性胆汁性肝硬化
BMJ. 1994;309(6953):491-2. doi: 10.1136/bmj.309.6953.491.
引用本文的文献
1
Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum gamma-glutamyltranspeptidase levels.熊去氧胆酸治疗血清γ-谷氨酰转肽酶水平升高的慢性丙型病毒性肝炎的疗效
J Gastroenterol. 1996 Feb;31(1):75-80. doi: 10.1007/BF01211190.
2
Percutaneous hepaticoneojejunostomy and choledochocholedochal reanastomosis using metallic stents: technical note.使用金属支架的经皮肝管空肠吻合术和胆总管-胆总管再吻合术：技术说明
Cardiovasc Intervent Radiol. 1992 Jul-Aug;15(4):256-60. doi: 10.1007/BF02733935.
本文引用的文献
1
Effect of steroid therapy on the clinical and laboratory features of primary biliary cirrhosis.
Gastroenterology. 1955 Feb;28(2):193-207; discussion, 208-15.
2
Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.熊去氧胆酸治疗期间透亮胆结石的钙化
Br Med J (Clin Res Ed). 1981 Sep 5;283(6292):645-6. doi: 10.1136/bmj.283.6292.645.
3
A clinical trial of levamisole in primary biliary cirrhosis.左旋咪唑治疗原发性胆汁性肝硬化的临床试验。
Postgrad Med J. 1982 Nov;58(685):701-3. doi: 10.1136/pgmj.58.685.701.
4
Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes.鹅去氧胆酸和熊去氧胆酸对分离的成人肝细胞的作用。
Dig Dis Sci. 1984 Dec;29(12):1123-30. doi: 10.1007/BF01317087.
5
Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.熊去氧胆酸治疗慢性活动性肝炎患者胆结石并随访两年：一项初步研究
Dig Dis Sci. 1985 Jul;30(7):642-9. doi: 10.1007/BF01308413.
6
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.硫唑嘌呤对原发性胆汁性肝硬化的有益作用及预后预测。一项国际试验的最终结果。
Gastroenterology. 1985 Nov;89(5):1084-91. doi: 10.1016/0016-5085(85)90213-6.
7
Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis.青霉胺治疗原发性胆汁性肝硬化患者的双盲对照试验。
Gut. 1985 Feb;26(2):114-9. doi: 10.1136/gut.26.2.114.
8
Granulocytopenia complicating colchicine therapy for primary biliary cirrhosis.
Gastroenterology. 1987 Dec;93(6):1231-5. doi: 10.1016/0016-5085(87)90249-6.
9
A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report.
J Hepatol. 1987 Aug;5(1):1-7. doi: 10.1016/s0168-8278(87)80053-3.
10
Faecal steroid loss in healthy subjects during short-term treatment with ursodeoxycholic acid.
J Steroid Biochem. 1987 Apr;26(4):503-7. doi: 10.1016/0022-4731(87)90064-1.
Zotero 插件